thoratec heart update2

http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aImw1nInTWfA

TOPIC ON THORATEC

``Everybody has had a buy rating on this stock for so long because of HeartMate II, which everybody should understand will control the market for only a brief period before it loses out to competitors,'' said Guterman in an interview. ``What's odd is everybody is so enthusiastic about this stock and pretty much everybody is pretty pessimistic about the long-term revenue potential for HeartMate II.''


"The mechanical hearts now being tested are smaller still, easier to implant, and may extend patients' lives by decades because they don't contain parts, such as ball bearings, that wear out over time, doctors and analysts say. Instead, the next- generation pumps use rotors suspended in a magnetic field, not ball bearings, to keep blood flowing.

``That's the cutting edge,'' Starling said. "